1. Home
  2. RKLB vs GMAB Comparison

RKLB vs GMAB Comparison

Compare RKLB & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Lab USA Inc.

RKLB

Rocket Lab USA Inc.

N/A

Current Price

$61.94

Market Cap

37.3B

Sector

Industrials

ML Signal

N/A

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

N/A

Current Price

$51.42

Market Cap

31.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RKLB
GMAB
Founded
2006
1999
Country
United States
Denmark
Employees
N/A
3119
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.3B
31.9B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
RKLB
GMAB
Price
$61.94
$51.42
Analyst Decision
Buy
Strong Buy
Analyst Count
21
12
Target Price
★ $93.10
$65.10
AVG Volume (30 Days)
★ 16.4M
6.2M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2.63
N/A
EPS
N/A
★ N/A
Revenue
★ $601,799,000.00
N/A
Revenue This Year
$62.85
$27.36
Revenue Next Year
$36.96
$21.44
P/E Ratio
★ N/A
$1.90
Revenue Growth
★ 37.96
N/A
52 Week Low
$37.57
$23.62
52 Week High
$150.85
$59.97

Technical Indicators

Market Signals
Indicator
RKLB
GMAB
Relative Strength Index (RSI) 53.13 58.85
Support Level $60.71 $25.91
Resistance Level $77.02 $59.97
Average True Range (ATR) 4.79 3.01
MACD 1.69 -0.57
Stochastic Oscillator 72.38 45.97

Price Performance

Historical Comparison
RKLB
GMAB

About RKLB Rocket Lab USA Inc.

Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, and rest of the world and earns key revenue from the United States.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: